The post discusses a new study using the Phenotypic Age (PhenoAge) clock to predict mortality risk in Parkinson's disease (PD) patients, finding that higher PhenoAge and its acceleration are strong independent predictors of death alongside factors like age, male sex, smoking, underweight, depression, LDL levels, and genetics. By analyzing 569 UK Biobank PD cases with Cox regression and a nomogram, the researchers demonstrate that PhenoAge can reliably stratify patients for targeted interventions. The author emphasizes that, while aging clocks still lack full mechanistic validation, accumulating outcome data—such as this mortality link—is the most practical way to assess their utility.
Comments
Want to join the conversation?